Report Categories
View AllRecent Articles
View All
Claros Mtg CMTG Stock The Bull Case Builds on Momentum 20260418
Splash SBEV Stock Large Cap Focus Smart Money Flows 20260416
How Zeo Energy ZEOWW prepares for market disruptions ZEOWW Q4 Earnings Zeo Energy Warrants Show No Financial Data
Kevin Warsh Poised for Fed Role Amid Internal Struggle Over Rate Cut Path
Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand
AI Economy Reshapes American Dream BlueCollar Workers May Gain as College Hiring Slows
Global Markets Navigate Volatility Amid Geopolitical Tensions Inflation and AI Disruption
Fresh US Strikes Complicate Iran Deal Geopolitical Risk Resurfaces
MOVE Q1 2026 Earnings EPS Surprises to the Upside Despite Negative Earnings
PNC Q1 2026 Earnings Modest EPS Beat Reflects Resilient Core Operations
Almonty Industries Q1 2026 Earnings EPS Misses Estimates as Loss Widens Shares Decline
CNTB Q1 2026 Earnings WiderthanExpected Loss as Development Pipeline Advances
PATK Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operational Execution
SLR Investment Corp Falls to 1297 as Selling Pressure Intensifies
Abony Acquisition Corp I Units AACOU Holds Near 10 as SPAC Trades Tightly
HF Sinclair DINO Moves Higher Refining Sector Strength and Key Resistance Ahead
Nexentis Technologies NXTS Gains 136 as Stock Tests Key Resistance Near 470
Bond Bull Market Poised for a Brief Pause but Remains Intact Expert Suggests
Prediction Markets Face Regulatory Crackdown 16 States in Legal Proceedings
Oregon Gas Tax Rejection Puts Jeff Merkleys Senate Seat in Play
Treasury Yield Surge Challenges RiskFree Status Opens Doors in Intermediate BBB and HighYield Bonds
The New Arms Race in Computing Power Governments Turn to Experimental AI Hardware
Barclays Reports 18 Profit Rise Raises Income Guidance
Nvidia Shares Dip Despite 85 Revenue Surge as AI Boom Continues Investor Caution Emerges
Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement
Morgan Stanley Lowers Edison International Price Target to 64 on April Utility Review
Novartis Lifts FullYear Sales and Profit Outlook Amid Strong Drug Portfolio Performance